AbbVie
A company that is spending $10 billion on a cancer-focused company that spent four decades on the path to its first FDA approval.
Best podcasts with AbbVie
Ranked by the Snipd community
Nov 30, 2023 • 29min
284: AbbVie’s big deal, CAR-T’s risks, & getting a biotech job
AbbVie, a company spending $10 billion on a cancer-focused company on its first FDA approval. Implications for biotech in 2023 and oncology. Safety concerns for CAR-T cancer treatment. Slumping industry job market. Curious explanations for clinical failures.
